home / stock / asln / asln articles

ASLN Articles, ASLAN Pharmaceuticals Limited - From 07/15/24

Stock Information
Company Name: ASLAN Pharmaceuticals Limited
Stock Symbol: ASLN
Market: NASDAQ
Website: aslanpharma.com
Menu
ASLN ASLN Quote ASLN Short ASLN News ASLN Articles ASLN Message Board
Get ASLN Alerts

News, Short Squeeze, Breakout and More Instantly...
Dow Jumps Over 200 Points; NY Empire State Manufacturing Index Falls In July | Benzinga

U.S. stocks traded higher this morning, with the Dow Jones index gaining more than 200 points on Monday. Following the market opening Monday, the D...
Why Vuzix Shares Are Trading Higher By Around 15%; Here Are 20 Stocks Moving Premarket | Benzinga

Shares of Vuzix Corporation (NASDAQ:VUZI) rose sharply in today's pre-market trading after the company disclosed a strategic partnership with ...

ASLAN Pharmaceuticals to Present Additional Data From Interim Analysis of TREK-DX Phase 2 Study of Eblasakimab in Dupilumab-Experienced Atopic Dermatitis Patients During Virtual KOL Event | Benzinga

New positive data from an additional analysis of dupilumab-experienced patients treated with eblasakimab 400mg, weekly over 16 weeks further supp...

ASLAN Pharmaceuticals to Host KOL Panel Discussion on Treatment Options for Atopic Dermatitis Patients With an Inadequate Response to Dupilumab | Benzinga

ASLAN management will present new data from the interim analysis of the TREK-DX study Register here to attend the webinar event on May 7, 2024 at...
ASLAN Pharmaceuticals Announces Late Breaking Abstract on Eblasakimab in COPD Accepted for Presentation at the American Thoracic Society International Conference | Benzinga

SAN MATEO, Calif. and SINGAPORE, April 24, 2024 (GLOBE NEWSWIRE) -- ASLAN Pharmaceuticals (NASDAQ:ASLN), a clinical-stage, immunology-focused bi...

Aslan Pharmaceuticals to Present at the 2nd Annual H.C. Wainwright Autoimmune and Inflammatory Disease Virtual Conference: Skin Diseases, Conditions and Disorders | Benzinga

SAN MATEO, Calif. and SINGAPORE, March 27, 2024 (GLOBE NEWSWIRE) -- ASLAN Pharmaceutical (NASDAQ:ASLN), a clinical-stage, immunology-focused bio...

ASLAN Pharmaceuticals Receives Favorable Opinion From the European Patent Office on Composition of Matter Patent Application for Farudodstat | Benzinga

New Composition of Matter Patent for farudodstat would strengthen intellectual property protection and provide commercial exclusivity for farudod...
ASLAN Pharmaceuticals Announces Participation in January Investor Conferences | Benzinga

SAN MATEO, Calif. and SINGAPORE, Jan. 02, 2024 (GLOBE NEWSWIRE) -- ASLAN Pharmaceuticals (NASDAQ:ASLN), a clinical-stage, immunology-focused bio...

ASLAN Pharmaceuticals Provides Year-End Update on Its Eblasakimab and Farudodstat Programs | Benzinga

Following the successful TREK-AD Phase 2b study of eblasakimab in moderate-to-severe atopic dermatitis, process is underway to identify potential...

ASLAN Pharmaceuticals to Participate in the 35th Annual Piper Sandler Healthcare Conference | Benzinga

SAN MATEO, Calif. and SINGAPORE, Nov. 20, 2023 (GLOBE NEWSWIRE) -- ASLAN Pharmaceuticals (NASDAQ:ASLN), a clinical-stage, immunology focused bio...
Previous 10 Next 10